|
|||||
|
|
Safety and immunogenicity of a novel multivalent OspA vaccine against Lyme borreliosis in healthy adults: a double-blind,randomised, dose-escalation phase 1/2 trial |
|
| Authors: | Nina Wressnigg Eva-Maria Pöllabauer Gerald Aichinger Daniel Portsmouth Alexandra Löw-Baselli Sandor Fritsch Ian Livey Brian A Crowe Michael Schwendinger Peter Brühl Andreas Pilz Thomas Dvorak Julia Singer Clair Firth Benjamin Luft Bernhard Schmitt Markus Zeitlinger Markus Müller P Noel Barrett |
| Affiliation: | 1. Vaccine R&D, Baxter BioScience, Vienna, Austria;2. Global R&D, Baxter BioScience, Vienna, Austria;3. Vaccine R&D, Baxter BioScience, Orth an der Donau, Austria;4. Stony Brook University Medical Center, Stony Brook, NY, USA;5. Health Center Mainz, Mainz, Germany;6. Medical University of Vienna, Vienna, Austria;7. Institute of Tropical Medicine, University of Tübingen, Tübingen, Germany |
| Abstract: | |
| Keywords: | |
| 本文献已被 ScienceDirect 等数据库收录！ | |